Royal Bank of Canada’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,852
Closed -$36K 7287
2025
Q2
$36K Buy
28,852
+6,150
+27% +$7.59K ﹤0.01% 6060
2025
Q1
$25K Buy
22,702
+3,309
+17% +$5.45K ﹤0.01% 5834
2024
Q4
$39K Sell
19,393
-4,237
-18% -$13.1K ﹤0.01% 5809
2024
Q3
$102K Buy
23,630
+2,086
+10% +$11K ﹤0.01% 5330
2024
Q2
$127K Buy
21,544
+514
+2% +$4.08K ﹤0.01% 5116
2024
Q1
$150K Sell
21,030
-1,003
-5% -$7.14K ﹤0.01% 4925
2023
Q4
$178K Sell
22,033
-19,964
-48% -$110K ﹤0.01% 5200
2023
Q3
$259K Buy
41,997
+1,956
+5% +$14.4K ﹤0.01% 4570
2023
Q2
$352K Sell
40,041
-2,237
-5% -$24.8K ﹤0.01% 4229
2023
Q1
$311K Buy
42,278
+2,247
+6% +$20.1K ﹤0.01% 4261
2022
Q4
$324K Buy
40,031
+10,935
+38% +$118K ﹤0.01% 4472
2022
Q3
$390K Buy
29,096
+2,827
+11% +$43.4K ﹤0.01% 4236
2022
Q2
$428K Buy
26,269
+681
+3% +$11.3K ﹤0.01% 4212
2022
Q1
$584K Buy
25,588
+9,023
+54% +$162K ﹤0.01% 4157
2021
Q4
$386K Buy
16,565
+5,926
+56% +$238K ﹤0.01% 4705
2021
Q3
$626K Buy
10,639
+7,053
+197% +$511K ﹤0.01% 4163
2021
Q2
$329K Buy
3,586
+2,392
+200% +$319K ﹤0.01% 4643
2021
Q1
$161K Sell
1,194
-273
-19% -$32.9K ﹤0.01% 5109
2020
Q4
$162K Buy
1,467
+534
+57% +$57.7K ﹤0.01% 5011
2020
Q3
$88K Buy
933
+28
+3% +$2.85K ﹤0.01% 5043
2020
Q2
$105K Buy
905
+80
+10% +$7.8K ﹤0.01% 4827
2020
Q1
$68K Buy
825
+371
+82% +$40.6K ﹤0.01% 4994
2019
Q4
$56K Buy
454
+84
+23% +$7.13K ﹤0.01% 5400
2019
Q3
$28K Buy
370
+10
+3% +$738 ﹤0.01% 5355
2019
Q2
$24K Buy
+360
New +$38.2K ﹤0.01% 5622

Other funds holding HOOK

Royal Bank of Canada's HOOK Position: Q3 2025 in Review

Royal Bank of Canada sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 28,852 shares — an estimated $36K sold.

Royal Bank of Canada first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $626K in Q3 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Royal Bank of Canada reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 28,852 HOOKIPA Pharma shares in Q3 2025, an estimated $36K.
  • Royal Bank of Canada first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
  • Royal Bank of Canada's HOOKIPA Pharma position peaked at $626K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.